COMMUNIQUÉS West-GlobeNewswire

Caladrius Biosciences Reports 2018 Third Quarter Financial Results
08/11/2018
Development programs remain on track accompanied by continued strong fiscal management Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences [...]
Codexis Reports Third Quarter 2018 Financial Results
08/11/2018
Total revenues increase 70% to $16.9 million driven by higher product revenue and R&D revenue across an increased number of customers Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, Calif., Nov [...]
Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Second-Quarter 2019 Results
08/11/2018
Pre-Investigational New Drug (“IND”) meeting with the FDA expected to be held in calendar 2019 Second orphan designation anticipated in first half of calendar 2019 Submit first IND in calendar 2020 SAN DIEGO, Nov. 08, [...]
Alder BioPharmaceuticals® to Present at Two Upcoming November Investor Conferences
08/11/2018
BOTHELL, Wash., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
ICU Medical, Inc. Announces Third Quarter 2018 Results
08/11/2018
Company Modifies FY 2018 Guidance and Provides Initial FY 2019 Adjusted EBITDA Guidance SAN CLEMENTE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture [...]
The Joint Corp. Reports Third Quarter 2018 Financial Results
08/11/2018
- Increases Annual System-Wide Gross Sales 31%, Compared to Third Quarter 2017 - - Grows Revenue 23%, Compared to Third Quarter 2017 - - Sells 60 Franchise Licenses January through September 2018, up from 37 in 2017 [...]
Collegium Reports Third Quarter Financial Results
08/11/2018
Net Product Revenues were $70.2 million for the third quarter of 2018, a 487% increase versus third quarter of 2017 Thirteen exclusive ER oxycodone formulary wins announced for Xtampza ER effective January 1, 2019 Cash [...]
BioDelivery Sciences Reports Strong Third Quarter 2018 Financial Results
08/11/2018
BELBUCA ® continued on an accelerated growth trajectory, with revenue increasing 92% YOY and 27% versus prior quarter BELBUCA total prescriptions experienced its largest quarter over quarter increase since launch [...]
ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights
08/11/2018
-- Large, controlled clinical trial of avacopan in Hidradenitis Suppurativa (HS) on track to launch in late 2018 – -- $186 million in cash and investments at September 30, 2018 -- -- Received Orphan Drug Designation for [...]
Misonix Fiscal 2019 First Quarter Revenue Rises 29% to Record $9.4 Million
08/11/2018
FARMINGDALE, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Alphatec Reports Third Quarter 2018 Financial and Corporate Highlights
08/11/2018
CARLSBAD, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC,” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the [...]
Inovio Pharmaceuticals Reports 2018 Third Quarter Financial Results
08/11/2018
PLYMOUTH MEETING, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a late-stage biotechnology company focused on the development and commercialization of DNA immunotherapies targeted [...]
Dova Pharmaceuticals Reports Third Quarter 2018 Operating and Financial Results
08/11/2018
Third quarter net product sales of $2.9 million from DOPTELET ® (avatrombopag); 335 cumulative unique prescribers from launch through September 30, 2018 sNDA accepted for review by FDA for DOPTELET for the treatment of [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/11/2018
MENLO PARK, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
KemPharm, Inc. Reports Third Quarter 2018 Results
08/11/2018
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development Highlights: Announced positive topline results from KP415.E01 efficacy and safety trial in children with [...]
Sonoma Pharmaceuticals Reports Record Revenue in Second Quarter FY 2019
08/11/2018
• Total Revenue of $4.9 Million, up 13 % over June 2018 Quarter • Total Revenue up 14% over September 2017 Quarter Conference Call Begins at 4:30 pm EST Today PETALUMA, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Sonoma [...]
Viveve Reports Third Quarter 2018 Financial Results
08/11/2018
Continued commercial growth for Viveve ® System including record quarter of treatment tip sales Significant advancement of clinical programs targeting new indications in sexual function and stress urinary incontinence ( [...]
Yield10 Bioscience Announces Third Quarter 2018 Financial Results
08/11/2018
WOBURN, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today [...]
Helius Medical Technologies, Inc. Reports Third Quarter 2018 Financial Results
08/11/2018
NEWTOWN, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial [...]

Pages